A detailed history of Verition Fund Management LLC transactions in Absci Corp stock. As of the latest transaction made, Verition Fund Management LLC holds 60,410 shares of ABSI stock, worth $161,898. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,410
Holding current value
$161,898
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.97 - $4.49 $179,417 - $271,240
60,410 New
60,410 $230,000
Q3 2023

Nov 14, 2023

SELL
$1.28 - $2.41 $27,294 - $51,390
-21,324 Reduced 37.59%
35,400 $46,000
Q2 2023

Aug 14, 2023

BUY
$1.17 - $2.03 $24,450 - $42,422
20,898 Added 58.33%
56,724 $86,000
Q1 2023

May 15, 2023

BUY
$1.58 - $3.41 $56,605 - $122,166
35,826 New
35,826 $62,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $249M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.